Pharma-Bio Serv (PBSV) Share-based Compensation (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Share-based Compensation came in at $8619.0 in Q2 2026, up 128.1% on a YoY basis from $3778.7 in Q2 2025, and up 121.7% quarter-over-quarter from -$39716.0 in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Share-based Compensation (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Share-based Compensation for 17 consecutive years, with $8619.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Share-based Compensation rose 128.1% year-over-year to $8619.0; the trailing twelve-month figure through Apr 2026 stood at $69619.0 (up 246.85% YoY), and the FY2025 full-year result was $1.0 million, down 5.41% from the prior year.
- Share-based Compensation improved to $8619.0 in Q2 2026 per PBSV's latest filing, from -$39716.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $220778.0 in Q3 2022 and bottomed at -$417696.0 in Q4 2022.
- Historically, Share-based Compensation has averaged -$24933.5 across 5 years, with a median of $3772.5 in 2024.
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation slumped 542.01% in 2024, then jumped 439.29% in 2025.
- Over 5 years, Share-based Compensation stood at -$417696.0 in 2022, then surged by 100.16% to $684.0 in 2023, then surged by 359.94% to $3146.0 in 2024, then jumped by 39.83% to $4399.0 in 2025, then jumped by 95.93% to $8619.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $8619.0, -$39716.0, and $4399.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 462.14 Mn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 23.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 40.99 Mn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 9.77 Mn |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 21.00 Mn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 26.36 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 11.99 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | 11.44 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 3.46 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 8,619.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 8,619.00 |
| Jan 31, 2026 | -39,716.00 |
| Oct 31, 2025 | 4,399.00 |
| Jul 31, 2025 | 96,317.00 |
| Apr 30, 2025 | -30,677.00 |
| Jan 31, 2025 | -37,737.00 |
| Oct 31, 2024 | 3,146.00 |
| Jul 31, 2024 | 17,860.00 |
| Apr 30, 2024 | -65,417.00 |
| Jan 31, 2024 | 14,800.00 |
| Oct 31, 2023 | 684.00 |
| Jul 31, 2023 | 14,799.00 |
| Apr 30, 2023 | 14,800.00 |
| Jan 31, 2023 | 14,801.00 |
| Oct 31, 2022 | -417,696.00 |
| Jul 31, 2022 | 220,778.00 |
| Apr 30, 2022 | -122,030.00 |
| Jan 31, 2022 | -146,533.00 |
| Oct 31, 2021 | 358,563.00 |
| Jul 31, 2021 | -552,175.00 |